MedPath

a phase 3 study of chemotherapy folowed by surgery and postoperative chemotherapy compared to initial surgery followed by chemotherapy in advanced ovarian cancer

Phase 3
Conditions
Health Condition 1: null- epithelial cancer ovary
Registration Number
CTRI/2014/01/004363
Lead Sponsor
Sri Venkateswara Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Previously untreated patients with cytologically/histologically proven ovarian cancer showing peritoneal deposits outside the pelvis of >2cms either clinically/ radiologically

2.Patients with cytological/histologically proven ovarian cancer with regional lymph node metastasis

3.Patients with malignant pleural effusion confirmed to be of ovarian origin,

Exclusion Criteria

1.Patients with early stage ovarian cancer and those with peritoneal deposits <2 cms.

2.Patients with distant metastasis except mentioned above.

3.Nonepithelial tumors of ovary such as germ cell tumor, sexcord stromal tumor etc.

4.Patients who have been previously treated or started treatment outside the institute or recurrent lesions will be excluded.

5.Patients with poor performance status or medical contraindications for chemotherapy and/or surgery will be excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath